Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

T(14;19) is an unusual but distinct genomic alteration reported in low-grade B-cell lymphomas. This structural rearrangement places BCL3 in juxtaposition with IGH inducing proliferation and has been found in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone lymphoma (MZL), and other low-grade B-cell lymphomas. While there are some case series describing this in the context of other cytogenetic alterations, there are limited clinical cases examined from a molecular perspective. We herein describe a case of a low-grade B-cell lymphoma with t(14;19) resulting in IGH::BCL3 fusion on which we performed whole exome sequencing to investigate genetic variants that could contribute to its pathogenesis. We found pathogenic alterations including a variant in CXCR4 which has been shown to be recurrently mutated in different low-grade B-cell lymphomas including lymphoplasmacytic lymphoma (LPL) and MZL. We describe this interesting case in the context of its genomic findings and how it contributes to the literature as a whole.

Cite

CITATION STYLE

APA

Karrs, J. X., Sathyanarayana, S. H., Xu, X., Green, D. C., Kahn, W. A., Loo, E. Y., & Kaur, P. (2023). Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective. Journal of Hematopathology, 16(4), 217–221. https://doi.org/10.1007/s12308-023-00562-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free